<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34452462</PMID><DateCompleted><Year>2021</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2021</Year><Month>Aug</Month><Day>12</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>The Positive Rhinovirus/Enterovirus Detection and SARS-CoV-2 Persistence beyond the Acute Infection Phase: An Intra-Household Surveillance Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1598</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13081598</ELocationID><Abstract><AbstractText>We aimed to assess the duration of nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA persistence in adults self-confined at home after acute infection; and to identify the associations of SARS-CoV-2 persistence with respiratory virus co-detection and infection transmission. A cross-sectional intra-household study was conducted in metropolitan Barcelona (Spain) during the time period of April to June 2020. Every adult who was the first family member reported as SARS-CoV-2-positive by reverse transcription polymerase chain reaction (RT-PCR) as well as their household child contacts had nasopharyngeal swabs tested by a targeted SARS-CoV-2 RT-PCR and a multiplex viral respiratory panel after a 15 day minimum time lag. Four-hundred and four households (404 adults and 708 children) were enrolled. SARS-CoV-2 RNA was detected in 137 (33.9%) adults and 84 (11.9%) children. Rhinovirus/Enterovirus (RV/EV) was commonly found (83.3%) in co-infection with SARS-CoV-2 in adults. The mean duration of SARS-CoV-2 RNA presence in adults' nasopharynx was 52 days (range 26-83 days). The persistence of SARS-CoV-2 was significantly associated with RV/EV co-infection (adjusted odds ratio (aOR) 9.31; 95% CI 2.57-33.80) and SARS-CoV-2 detection in child contacts (aOR 2.08; 95% CI 1.24-3.51). Prolonged nasopharyngeal SARS-CoV-2 RNA persistence beyond the acute infection phase was frequent in adults quarantined at home during the first epidemic wave; which was associated with RV/EV co-infection and could enhance intra-household infection transmission.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brotons</LastName><ForeName>Pedro</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Sant Cugat, 08195 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jordan</LastName><ForeName>Iolanda</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatric Intensive Care Unit, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassat</LastName><ForeName>Quique</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0003-0875-7596</Identifier><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investiga&#xe7;&#xe3;o em Sa&#xfa;de de Manhi&#xe7;a (CISM), Manhi&#xe7;a 1929, Mozambique.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic-Universitat de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Instituci&#xf3; Catalana de Recerca i Estudis Avan&#xe7;ats (ICREA), 08010 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henares</LastName><ForeName>Desiree</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fernandez de Sevilla</LastName><ForeName>Mariona</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ajanovic</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic-Universitat de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Redin</LastName><ForeName>Alba</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Sant Cugat, 08195 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fumado</LastName><ForeName>Vicky</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baro</LastName><ForeName>Barbara</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0001-7780-1744</Identifier><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic-Universitat de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Claverol</LastName><ForeName>Joana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Clinical Research Unit, Fundaci&#xf3; Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Varo</LastName><ForeName>Rosauro</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-4282-5572</Identifier><AffiliationInfo><Affiliation>ISGlobal, Hospital Cl&#xed;nic-Universitat de Barcelona, 08036 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuadras</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0001-8780-1764</Identifier><AffiliationInfo><Affiliation>Clinical Research Unit, Fundaci&#xf3; Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecht</LastName><ForeName>Jochen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Centre for Genomic Regulation (CRG), Genomics Unit, 08003 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barrabeig</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epidemiological Surveillance Unit, Department of Health, Generalitat de Catalunya, 08907 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Garcia</LastName><ForeName>Juan Jose</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Launes</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0913-9303</Identifier><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Pediatrics Department, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz-Almagro</LastName><ForeName>Carmen</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0001-5586-404X</Identifier><AffiliationInfo><Affiliation>Pediatric Infectious Diseases Research Group, Institut de Recerca Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, School of Medicine, Universitat Internacional de Catalunya, Sant Cugat, 08195 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consorcio de Investigacion Biom&#xe9;dica en Red Epidemiologia y Salud P&#xfa;blica (CIBERESP), 28029 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Epidemiology, Hospital Sant Joan de D&#xe9;u, Esplugues de Llobregat, 08950 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Not applicable</GrantID><Agency>Stavros Niarchos Foundation</Agency><Country/></Grant><Grant><GrantID>Not applicable</GrantID><Agency>Banco de Santander</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="N">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087123" MajorTopicYN="N">COVID-19 Nucleic Acid Testing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060085" MajorTopicYN="Y">Coinfection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005192" MajorTopicYN="N">Family Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009305" MajorTopicYN="N">Nasopharynx</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010850" MajorTopicYN="N">Picornaviridae Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">RT-PCR</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">household</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>The funding sources had no role in the writing of the manuscript or in the decision to submit for publication. C.M.-A. reports grants to her organization from BioM&#xe8;rieux, Roche Diagnostics, Qiagen, BioFire Diagnostics, Alere and Genomica, outside the submitted work, and personal fees from BioM&#xe8;rieux, Roche Diagnostics and Qiagen for presentations in satellite symposia outside of the submitted work. P.B. reports personal fees from Roche Diagnostics for a presentation in a satellite symposium outside the submitted work. The rest of the authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34452462</ArticleId><ArticleId IdType="pmc">PMC8402816</ArticleId><ArticleId IdType="doi">10.3390/v13081598</ArticleId><ArticleId IdType="pii">v13081598</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  . Novel Coronavirus (2019-nCoV). Situation Report&#x2014;1. 21 January 2020. WHO; Geneva, Switzerland: 2020.  [(accessed on 26 June 2021)].  Available online:  https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200121-sitrep-1-2019-ncov.pdf.</Citation></Reference><Reference><Citation>European Centre for Disease Prevention and Control  COVID-19 Situation Update Worldwide, as of Week 24, updated 24 June 2021.  [(accessed on 26 June 2021)]; Available online:  from:https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases.</Citation></Reference><Reference><Citation>Government Decrees State of Emergency to Stop Spread of Coronavirus COVID-19. Council of Ministers; Madrid, Spain: 2020.  [(accessed on 26 June 2021)].  Available online:  https://www.lamoncloa.gob.es/lang/en/gobierno/councilministers/Paginas/2020/20200314council-extr.aspx.</Citation></Reference><Reference><Citation>Tang Y.-W., Schmitz J.E., Persing D.H., Stratton C.W. Laboratory diagnosis of COVID-19: Current issues and challenges. J. Clin. Microbiol. 2020;58:e00512&#x2013;e00520. doi: 10.1128/JCM.00512-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00512-20</ArticleId><ArticleId IdType="pmc">PMC7269383</ArticleId><ArticleId IdType="pubmed">32245835</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Qi T., Liu L., Ling Y., Qian Z., Li T., Li F., Xu Q., Zhang Y., Xu S., et al. Clinical progression of patients with COVID-19 in Shanghai, China. J. Infect. 2020;80:e1&#x2013;e6. doi: 10.1016/j.jinf.2020.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.03.004</ArticleId><ArticleId IdType="pmc">PMC7102530</ArticleId><ArticleId IdType="pubmed">32171869</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao A.T., Tong Y.X., Gao C., Zhu L., Zhang Y.J., Zhang S. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study. J. Clin. Virol. 2020;127:104346. doi: 10.1016/j.jcv.2020.104346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104346</ArticleId><ArticleId IdType="pmc">PMC7151472</ArticleId><ArticleId IdType="pubmed">32361324</ArticleId></ArticleIdList></Reference><Reference><Citation>To K.K., Tsang O.T., Leung W.S., Tam A.R., Wu T.C., Lung D.C., Yip C.C., Cai J.P., Chan J.M., Chik T.S., et al. Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: An observational cohort study. Lancet Infect. Dis. 2020;20:565&#x2013;574. doi: 10.1016/S1473-3099(20)30196-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30196-1</ArticleId><ArticleId IdType="pmc">PMC7158907</ArticleId><ArticleId IdType="pubmed">32213337</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazra A., Collison M., Pisano J., Kumar M., Oehler C., Ridgway J.P. Coinfections with SARS-CoV-2 and other respiratory pathogens. Infect. Control. Hosp. Epidemiol. 2020;41:1228&#x2013;1229. doi: 10.1017/ice.2020.322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2020.322</ArticleId><ArticleId IdType="pmc">PMC7360954</ArticleId><ArticleId IdType="pubmed">32616098</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh V., Upadhyay P., Reddy J., Granger J. SARS-CoV-2 respiratory co-infections: Incidence of viral and bacterial co-pathogens. Int. J. Infect. Dis. 2021;105:617&#x2013;620. doi: 10.1016/j.ijid.2021.02.087.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.02.087</ArticleId><ArticleId IdType="pmc">PMC7905386</ArticleId><ArticleId IdType="pubmed">33640570</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowak M.D., Sordillo E.M., Gitman M.R., PanizMondolfi A.E. Coinfection in SARS-CoV-2 infected patients: Where are influenza virus and rhinovirus/enterovirus? J. Med. Virol. 2020;92:1699&#x2013;1700. doi: 10.1002/jmv.25953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25953</ArticleId><ArticleId IdType="pmc">PMC7267652</ArticleId><ArticleId IdType="pubmed">32352574</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D., Quinn J., Pinsky B., Shah N.H., Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. 2020;323:2085&#x2013;2086. doi: 10.1001/jama.2020.6266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6266</ArticleId><ArticleId IdType="pmc">PMC7160748</ArticleId><ArticleId IdType="pubmed">32293646</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia W., Shao J., Guo Y., Peng X., Li Z., Hu D. Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults. Pediatr. Pulmonol. 2020;55:1169&#x2013;1174. doi: 10.1002/ppul.24718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.24718</ArticleId><ArticleId IdType="pmc">PMC7168071</ArticleId><ArticleId IdType="pubmed">32134205</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinky L., Dobrovolny H.M. SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial? J. Med. Virol. 2020;92:2623&#x2013;2630. doi: 10.1002/jmv.26098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26098</ArticleId><ArticleId IdType="pmc">PMC7300957</ArticleId><ArticleId IdType="pubmed">32557776</ArticleId></ArticleIdList></Reference><Reference><Citation>Wee L.E., Ko K.K.K., Ho W.Q., Kwek G.T.C., Tan T.T., Wijaya L. Community-acquired viral respiratory infections amongst hospitalized inpatients during a COVID-19 outbreak in Singapore: Co-infection and clinical outcomes. J. Clin. Virol. 2020;128:104436. doi: 10.1016/j.jcv.2020.104436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2020.104436</ArticleId><ArticleId IdType="pmc">PMC7235565</ArticleId><ArticleId IdType="pubmed">32447256</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X., Ge Y., Wu T., Zhao K., Chen Y., Wu B., Zhu F., Zhu B., Cui L. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. doi: 10.1016/j.virusres.2020.198005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198005</ArticleId><ArticleId IdType="pmc">PMC7213959</ArticleId><ArticleId IdType="pubmed">32408156</ArticleId></ArticleIdList></Reference><Reference><Citation>Brotons P., Launes C., Buetas E., Fumado V., Henares D., de Sevilla M.F., Redin A., Fuente-Soro L., Cuadras D., Mele M., et al. Susceptibility to SARS-CoV-2 infection among children and adults: A seroprevalence study of family households in the Barcelona metropolitan region, Spain. Clin. Infect. Dis. 2020;72:e970&#x2013;e977. doi: 10.1093/cid/ciaa1721.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa1721</ArticleId><ArticleId IdType="pmc">PMC7717181</ArticleId><ArticleId IdType="pubmed">33180914</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., GU X., et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao A.T., Tong Y.X., Zhang S. False negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence. J. Med. Virol. 2020;92:1755&#x2013;1756. doi: 10.1002/jmv.25855.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.25855</ArticleId><ArticleId IdType="pmc">PMC7262304</ArticleId><ArticleId IdType="pubmed">32270882</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan J., Kou S., Liang Y., Zeng J., Pan Y., Liu L. Polymerase chain reaction assays reverted to positive in 25 discharged patients with COVID-19. Clin. Infect. Dis. 2020;71:2230&#x2013;2232. doi: 10.1093/cid/ciaa398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa398</ArticleId><ArticleId IdType="pmc">PMC7184423</ArticleId><ArticleId IdType="pubmed">32266381</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohn Y., Jeong S.J., Chung W.S., Hyun J.H., Baek Y.J., Cho Y., Kim J.H., Ahn J.Y., Choi J.Y., Yeom J.S., et al. Assessing viral shedding and infectivity of asymptomatic or mildly symptomatic patients with COVID-19 in a later phase. J. Clin. Med. 2020;9:2924. doi: 10.3390/jcm9092924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092924</ArticleId><ArticleId IdType="pmc">PMC7563591</ArticleId><ArticleId IdType="pubmed">32927798</ArticleId></ArticleIdList></Reference><Reference><Citation>Laferl H., Kelani H., Seitz T., Holzer B., Zimpernik I., Steinrigl A., Schmoll F., Wenisch C., Allerberger F. An approach to lifting self-isolation for health care workers with prolonged shedding of SARS-CoV-2 RNA. Infection. 2021;49:95&#x2013;101. doi: 10.1007/s15010-020-01530-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-020-01530-4</ArticleId><ArticleId IdType="pmc">PMC7538033</ArticleId><ArticleId IdType="pubmed">33025521</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard J., Dust K., Funk D., Strong J.E., Alexander D., Garnett L., Boodman C., Bello A., Hedley A., Schiffman Z., et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin. Infect. Dis. 2020;71:2663&#x2013;2666. doi: 10.1093/cid/ciaa638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciaa638</ArticleId><ArticleId IdType="pmc">PMC7314198</ArticleId><ArticleId IdType="pubmed">32442256</ArticleId></ArticleIdList></Reference><Reference><Citation>La Scola B., Le Bideau M., Andreani J., Hoang V.T., Grimaldier C., Colson P., Gautret P., Raoult D. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1059&#x2013;1061. doi: 10.1007/s10096-020-03913-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10096-020-03913-9</ArticleId><ArticleId IdType="pmc">PMC7185831</ArticleId><ArticleId IdType="pubmed">32342252</ArticleId></ArticleIdList></Reference><Reference><Citation>Arons M.M., Hatfield K.M., Reddy S.C., Kimball A., James A., Jacobs J.R., Taylor J., Spicer K., Bardossy A.C., Oakley L.P., et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. N. Engl. J. Med. 2020;382:2081&#x2013;2090. doi: 10.1056/NEJMoa2008457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2008457</ArticleId><ArticleId IdType="pmc">PMC7200056</ArticleId><ArticleId IdType="pubmed">32329971</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kr&#xfc;ger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271&#x2013;280.e8. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy R.C., Lai Y., Barrow K.A., Hamerman J.A., Lacy-Hulbert A., Piliponsky A.M., Ziegler S.F., Altemeier W.A., Debley J.S., Gharib S.A., et al. Effects of asthma and human rhinovirus A16 on the expression of SARS-CoV-2 entry factors in human airway epithelium. Am. J. Respir. Cell Mol. Biol. 2020;63:859&#x2013;863. doi: 10.1165/rcmb.2020-0394LE.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2020-0394LE</ArticleId><ArticleId IdType="pmc">PMC7790138</ArticleId><ArticleId IdType="pubmed">32946274</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat. Med. 2005;11:875&#x2013;879. doi: 10.1038/nm1267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1267</ArticleId><ArticleId IdType="pmc">PMC7095783</ArticleId><ArticleId IdType="pubmed">16007097</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., et al. Angiotensin converting enzyme 2 protects from severe acute lung failure. Nature. 2005;436:112&#x2013;116. doi: 10.1038/nature03712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03712</ArticleId><ArticleId IdType="pmc">PMC7094998</ArticleId><ArticleId IdType="pubmed">16001071</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauer S.A., Grantz K.H., Bi Q., Jones F.K., Zheng Q., Meredith H.R., Azman A.S., Reich N.G., Lessler J. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Ann. Intern. Med. 2020;172:577&#x2013;582. doi: 10.7326/M20-0504.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-0504</ArticleId><ArticleId IdType="pmc">PMC7081172</ArticleId><ArticleId IdType="pubmed">32150748</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>